Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Istradefylline in Restless Legs Syndrome
NCT00199446Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Jul 2005
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in restless legs syndrome (RLS) comparing Istradefylline 40mg with Placebo (2 arms). Primary endpoint: Restless Legs Syndrome Rating Scale Score at 6 weeks. Started Jul 2005; status: completed.
02
Drugs
Istradefylline
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00199446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199446.